|
|
Developing Countries
Abbott Slashes HIV Drug Price For Developing Nations
Tuesday, August 15, 2006
Still struggling with how to protect its patent rights, drug maker Abbott Laboratories Inc. has said it will launch new initiatives aimed at expanding the availability of its new HIV medicine in the developing world. |
WHO To Probe Global Drug Patent System
Tuesday, May 30, 2006
Amid growing criticism that poor nations are being denied access to crucial medicines, vaccines and diagnostic tests, the World Health Organization said it plans to review whether the international drug patent system curbs the ability of developing countries to obtain patented medical treatments. |
Senator Proposes Compulsory Patent Licensing Bill
Friday, May 26, 2006
Vermont Sen. Patrick Leahy introduced a compulsory patent licensing bill to the Senate on Thursday that would enable U.S. generic drug firms to make low-cost generic versions of patented medicines for export to the poorest nations. |
Superpatents Spark Debate Over IP Issues
Friday, May 05, 2006
With the advent of global health crises such as HIV/AIDS, global trading rules have been amended in recent years to provide poor countries with the right to break drug patents and produce cheap generic drugs. |
Boston Scientific And Angiotech Win Stent Suit
Thursday, May 04, 2006
Medical device makers Boston Scientific Corp. and Angiotech Pharmaceuticals Inc. have emerged victorious in a patent dispute after a Dutch court ruled Sahajanand Medical Technologies Pvt. Ltd.’s drug-eluting stent violated two claims of an Angiotech patent. |
Movie Studios' New Piracy Losses Questioned
Wednesday, May 03, 2006
A two-year study of global movie piracy, which included illegal Internet downloads for the first time, has revealed stunning financial losses for the U.S. movie industry, but some experts question the accuracy of the data that will be used as a “roadmap” to fight piracy worldwide. |
IP Blacklist Points To China and Russia
Monday, May 01, 2006
China and Russia topped the list as the most serious offenders of intellectual property laws and enforcement, according to the U.S. Trade Representative’s “Special 301” report to Congress. |
E.U. Backs WTO Bid For Cheaper Drugs For Poor Nations
Friday, April 28, 2006
In a move that could help some of the world’s poorest countries gain improved access to affordable medicines, the European Commission this week formally recommended that European Union member states ratify a proposed amendment to World Trade Organization law that would allow companies to export generic drugs under compulsory licensing agreements. |
WIPO Adopts Global Trademark Treaty In Singapore
Wednesday, March 29, 2006
Marking what industry professionals say is a milestone in global trademark regulation, a new international treaty on trademarks has been adopted by a group of intellectual property rights experts and member states of the United Nations’ World Intellectual Property Organization. |
WIPO Aims To Revise Global Trademark Rules
Wednesday, March 15, 2006
Intellectual property rights experts meeting at the United Nations’ World Intellectual Property Organization conference in Singapore are revising a global trademark treaty, with plans to introduce electronic filing processes and define trademark protection for such non-traditional items as holograms, sounds and smells. |
Group Moves To Thwart Tamiflu Patent In India
Monday, February 27, 2006
Under India’s new patent laws allowing public opposition to patent grants, a Bangalore-based public interest group is preparing to file a pre-grant opposition to Roche’s Tamiflu, one of two drugs used to treat avian influenza. |
Germany Tops Madrid Protocol List, U.S. Lands 3rd
Thursday, February 09, 2006
As international trademark applications skyrocketed over the past year, Germany took top honors again for the most applications filed with the World Intellectual Property Organization, while the U.S. failed to live up to early predictions once more. |
Pfizer Wins Lipitor Patent Challenge
Friday, December 16, 2005
A collective sigh of relief must have been audible at Pfizer’s headquarters on Friday, after the drug maker successfully fought off a gutsy patent challenge to the world’s best-selling drug. |
U.S. Welcomes New WTO Compulsory Licensing Policy
Tuesday, December 06, 2005
The U.S. government put its stamp of approval on new compulsory licensing rules by the World Trade Organization, which dramatically decrease intellectual property barriers faced by developing countries fighting life threatening diseases. |
E.U. OKs Compulsory Licensing For Drug Exports
Thursday, December 01, 2005
In a move that will allow generics to be exported to developing countries under strict conditions, The European Parliament approved Thursday a European Commission proposal for compulsory licensing of patented drugs. |
WTO Extends Compliance Deadline For Poorest Countries
Tuesday, November 29, 2005
The World Trade Organization has given the world’s poorest countries seven more years to provide protection for intellectual property under the WTO’s statutes, extending the deadline from January 2006 to January 2013. |
Brand Owners Cheer Starbucks Trademark Victory
Thursday, November 17, 2005
Starbucks’ victory in its bitter fight to protect its brand name in Russia shows that trademark rights are beginning to gain a foothold in markets that were once safe havens for government-sanctioned knock-offs, experts say. |
India Looms As Growing Threat To U.S. Patent Firms
Wednesday, November 16, 2005
India’s patent prosecutors are becoming increasingly sophisticated, heightening the threat to U.S. law firms that are faced with an increasing number of clients eager to outsource their patent work. But some U.S. boutiques are eyeing India's emergence as an opportunity. |
Drug Makers Gear Up For Round Two In Lipitor Case
Thursday, November 03, 2005
Although attention has now turned to the ongoing Lipitor litigation in the United States, Ranbaxy and Pfizer will continue their U.K. battle over the blockbuster anti-cholesterol drug after Ranbaxy was cleared to appeal a ruling of infringement handed down last month. |
Indian Drug Company To Copy Roche Flu Drug
Friday, October 14, 2005
In the midst of a global panic over a possible bird flu pandemic, an Indian drug company has decided to produce a generic version of Roche Pharmaceuticals’ Tamiflu treatment without permission from the patent holder. |
 |
French Tax Raises Money For Drugs—And IP Concerns
As international governments and drug companies struggle to find a balance between protection of intellectual property and the rights of poor nations to access crucial medications, a controversial new French initiative stands to fuel the growing debate by pressuring the pharmaceutical industry to lower its prices. |
|
Latest Articles
London Fog Lets Go Of Trademark
Monday, August 21, 2006
Still selling off its assets, bankrupt rainwear maker London Fog Group Inc. has unloaded its famed trademark, with Iconix Brand Group Inc. snapping up the recognizable brand for $30.5 million in cash and $7 million in stock.
|
No End In Sight In Plavix Battle
Monday, August 21, 2006
Attorneys spent a second day in court Monday arguing over whether Apotex’ generic version of the blockbuster blood thinner Plavix should be allowed on the market.
|
Lengthy Patent Battle Wages On For Microsoft
Monday, August 21, 2006
Timeline Inc. announced Monday that it has terminated a limited license with Microsoft Corp. for use of its patents with the software giant’s SQL Servers, and has asked a federal court to add Microsoft to a patent infringement lawsuit.
|
eBay Opinion Doesn’t Affect Preliminary Injunctions, Judge Rules
Monday, August 21, 2006
A federal judge has ruled that a landmark Supreme Court decision involving eBay only relates to permanent injunctions and not preliminary ones.
|
Federal Circuit Overturns Jury Verdict Against ACell
Monday, August 21, 2006
The Federal Circuit has overturned a jury verdict that found biotechnology company ACell Inc. liable for patent infringement of a tissue-engineering method for healing wounds and scars, ruling against Cook Biotech Inc. and Purdue Research Foundation.
|
Silicon Graphics To Retain Paul Hastings
Monday, August 21, 2006
Silicon Graphics Inc. has requested permission to hire Paul, Hastings, Janofsky & Walker LLP to act as its special intellectual property counsel.
|
Courts Write History on Permanent Injunctions In Patent Actions
Monday, August 21, 2006
Although a few more pages have been filled on the subject, there are still more pages that need to be written before the full impact and proper manner of applying the logic set forth in eBay will be understood, say Anthony F. Lo Cicero and Charles R. Macedo of Amster, Rothstein & Ebenstein LLP.
|
DexCom Scores Stay, Partial Dismissal In Abbott Suit
Friday, August 18, 2006
DexCom Inc. revealed Friday that it received a favorable ruling in a patent infringement dispute with rival Abbott Diabetes Care Inc. over technology related to glucose monitors used by diabetics.
|
EchoStar Wins Block Of Damaging DVR Injunction
Friday, August 18, 2006
The U.S. Courts of Appeals for the Federal Circuit Friday blocked a temporary injunction that would have prevented Echostar Communication Corp. from selling some of its digitial video recorders and stopped the service of about 4 million DVRs within 30 days.
|
Gloves Come Off In Plavix Battle
Friday, August 18, 2006
Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.
|
|
|
